ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Allergan
WAREHOUSE
International Warehouse 2
SUBSTANCE
Bimatoprost
Introducing LUMIGAN? 0.01%, a trusted prescription eye drop solution that has gained FDA approval for its effectiveness in reducing elevated intraocular pressure in patients diagnosed with open-angle glaucoma or ocular hypertension.
Managing high eye pressure is vital for glaucoma patients, and LUMIGAN? 0.01% is specifically formulated to help. This ophthalmic solution works by targeting and lowering intraocular pressure, making it an essential part of treatment for those facing the challenges of open-angle glaucoma or ocular hypertension.
Indication
LUMIGAN? (bimatoprost ophthalmic solution) 0.01% is clinically indicated for the reduction of high intraocular pressure (IOP) in individuals with open-angle glaucoma or ocular hypertension, ensuring effective management of this condition.
Dosage and Administration
The recommended dosage is one drop in the affected eye(s) once daily in the evening. It?s crucial not to exceed this dosage, as using LUMIGAN? more than once a day may diminish its effectiveness in lowering intraocular pressure. Patients can expect a noticeable reduction in pressure starting around 4 hours after the initial dose, with peak effects occurring approximately 8 to 12 hours later.